Africa CDC

To reinforce continental coordination, Africa CDC has convened an Extraordinary Meeting of African Ministers of Health for 28 October 2026.

The company has developed an integrated value chain around cinchona cultivation, quinine production and pharmaceutical manufacturing, with malaria treatment forming an important part of its activities.

The meeting brought together leaders and partners from both regions to discuss how country led priorities, stronger regional capacity and predictable financing can strengthen health systems and improve preparedness for future health emergencies.

The European Union has mobilised €500 million (US$586 million) in emergency aid, vaccines, treatment and health security support for the Great Lakes and Uganda region.

Africa CDC will participate in the meeting, with Director General H.E. Dr Jean Kaseya representing the African Union’s 55 Member States and the continent’s 1.5 billion people.

The Task Force will develop options and recommendations for consideration by the Eightieth World Health Assembly.

Following a review of the latest epidemiological data, the ECG noted that the DRC had recorded 4,449 confirmed Ebola cases and 2,061 confirmed deaths, representing a case-fatality rate of 46.3%.

The findings will inform a continental report intended to support evidence-based policymaking, strengthen accountability and accelerate efforts to prevent maternal and newborn deaths across Africa.

Under the agreements, MSD will work with Aspen Pharmacare in South Africa, Quality Chemicals Industries Limited (QCIL) in Uganda and Universal Corporation Limited (UCL) in Kenya.